EBSCO Logo
Connecting you to content on EBSCOhost
Results
Title

What's new in cardiac amyloidosis? Pharmacological treatment, physical activity, and care of patients with transthyretin cardiac amyloidosis.

Authors

Zaidel, Ezequiel J.; Song, Sol C.; Sterba, Juan J.; Piccinato, Agustina; Ramos, María Candelaria; Cacia, Silvina L.

Abstract

Awareness, proper diagnosis and treatment of cardiac amyloidosis have increased, but there are still several unmet needs that have to be addressed for the optimal care of the disease. In this comprehensive review, we describe current and future treatments for both hereditary and wild-type TTR cardiac amyloidosis and also review lifestyle, including current challenges and opportunities for specific dietary concerns and exercise sports for these patients.

Subjects

CARDIAC amyloidosis; SMALL interfering RNA; HEART failure; DRUG therapy; CARDIAC patients

Publication

Therapeutic Advances in Cardiovascular Disease, 2024, Vol 18, p1

ISSN

1753-9447

Publication type

Academic Journal

DOI

10.1177/17539447241295957

EBSCO Connect | Privacy policy | Terms of use | Copyright | Manage my cookies
Journals | Subjects | Sitemap
© 2025 EBSCO Industries, Inc. All rights reserved